Patent ID: 8808742

Claim:
A pharmaceutical composition comprising: i) from about 20 mg to about 500 mg of a compound of structure: or a pharmaceutically acceptable salt thereof; and ii) a pharmaceutically acceptable carrier or vehicle, and wherein at least one of the following conditions A), B), C), D) and/or E) is satisfied A) the pharmaceutically acceptable carrier or vehicle comprises silicified microcrystalline cellulose; B) the pharmaceutically acceptable carrier or vehicle comprises microcrystalline cellulose which is from about 80% to about 95% by weight of the composition; C) the pharmaceutical composition further comprises from about 1% to about 6% by weight croscarmellose sodium, from about 0.1% to about 5% by weight sodium lauryl sulfate, and from about 0.25% to about 1.5% by weight magnesium stearate; D) the pharmaceutical composition is in the form of a capsule and contains on a weight basis 20 mg of in a micronized form, and contains microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate and magnesium stearate; E) the pharmaceutical composition is in the form of a capsule and contains on a weight basis 4.2% of in a micronized form, and contains microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate and magnesium stearate.